rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
4
|
pubmed:dateCreated |
2006-6-7
|
pubmed:abstractText |
In this series of 32 adult-to-adult living related liver transplantations, we assessed the efficacy and safety of basiliximab in combination with a tacrolimus-based regimen. Basiliximab, a chimeric monoclonal antibody directed against the alpha chain of the interleukin-2 (IL-2) receptor (CD25), has been extensively evaluated as induction therapy for cadaveric liver transplant recipients.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0041-1345
|
pubmed:author |
pubmed-author:ArcadipaneAA,
pubmed-author:CintorinoDD,
pubmed-author:Di TrapaniGG,
pubmed-author:DoffriaEE,
pubmed-author:GridelliBB,
pubmed-author:GruttadauriaSS,
pubmed-author:MandalaLL,
pubmed-author:MarconLL,
pubmed-author:MassyJ MJM,
pubmed-author:MinerviniMM,
pubmed-author:MusumeciAA,
pubmed-author:PalazzoUU,
pubmed-author:PiazzaTT,
pubmed-author:SciannaGG,
pubmed-author:SpadaMM,
pubmed-author:VerzaroRR,
pubmed-author:VizziniGG,
pubmed-author:VolpesRR
|
pubmed:issnType |
Print
|
pubmed:volume |
38
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1106-8
|
pubmed:meshHeading |
pubmed-meshheading:16757278-Adolescent,
pubmed-meshheading:16757278-Adrenal Cortex Hormones,
pubmed-meshheading:16757278-Adult,
pubmed-meshheading:16757278-Aged,
pubmed-meshheading:16757278-Antibodies, Monoclonal,
pubmed-meshheading:16757278-Drug Administration Schedule,
pubmed-meshheading:16757278-Drug Therapy, Combination,
pubmed-meshheading:16757278-Family,
pubmed-meshheading:16757278-Graft Survival,
pubmed-meshheading:16757278-Humans,
pubmed-meshheading:16757278-Immunosuppression,
pubmed-meshheading:16757278-Immunosuppressive Agents,
pubmed-meshheading:16757278-Liver Cirrhosis,
pubmed-meshheading:16757278-Liver Transplantation,
pubmed-meshheading:16757278-Living Donors,
pubmed-meshheading:16757278-Middle Aged,
pubmed-meshheading:16757278-Recombinant Fusion Proteins,
pubmed-meshheading:16757278-Safety,
pubmed-meshheading:16757278-Survival Analysis,
pubmed-meshheading:16757278-Tacrolimus
|
pubmed:year |
2006
|
pubmed:articleTitle |
A safe immunosuppressive protocol in adult-to-adult living related liver transplantation.
|
pubmed:affiliation |
Istituto Mediterraneo Trapianti e Terapie ad Atta Specializzazione (IsMeTT), Italy, Palermo. sgruttadauria@ismett.edu
|
pubmed:publicationType |
Journal Article,
Clinical Trial
|